Sanofi takes a bold step by acquiring Blueprint MedicinesSanofi Makes Bold Move with $9.5 Billion Acquisition of Blueprint Medicines
By Ion Jauregui – Analyst at ActivTrades
French pharmaceutical giant Sanofi (EPA:SAN) has kicked off 2025 with a bold strategic move: the acquisition of U.S.-based biotech Blueprint Medicines (NASDAQ:BPMC) for up to $9.5 b
Key facts today
Sanofi's ADRs fell nearly 5.7% after mixed Phase 3 results for itepekimab, an antibody for COPD, with one trial meeting its primary goal and another failing.
4.44 EUR
5.56 B EUR
41.08 B EUR
1.11 B
About SANOFI
Sector
Industry
CEO
Paul Hudson
Website
Headquarters
Paris
Founded
1994
ISIN
FR0000120578
FIGI
BBG000PHQGN5
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Related stocks
Short on SANOFI (SAN)Short until 87.0 (support zone).
Strong selling pressure confirmed by two large red candles.
Recent green candle shows buyer hesitation (small body, upper wick).
No significant volume to support a bullish rebound.
RSI remains weak but needs surveillance.
Rebound lacking conviction.
Sanofi (SNY): A Strong Investment CaseCompany Overview:
Sanofi NASDAQ:SNY is a major pharmaceutical company based in Paris, with a market capitalization of $134 billion.
Investment Highlights:
Dividend Yield: 3.8%, more than double the S&P 500 average.
Drug Portfolio: Diverse and includes successful drug developments.
Pipeline: Prom
Is Sanofi Undervalue by 22% ?I wanted to share an analysis I've conducted on Sanofi over the past five years using both comparable methods and a 2-Stage DCF approach. According to my findings, the market value appears to be at least 22% undervalued in comparison with its fair value. Moreover, considering the post-COVID effects
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 4SAN is featured.
Frequently Asked Questions
The current price of 4SAN is 84.27 EUR — it has increased by 2.72% in the past 24 hours. Watch SANOFI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange SANOFI stocks are traded under the ticker 4SAN.
4SAN stock has fallen by −1.98% compared to the previous week, the month change is a −8.90% fall, over the last year SANOFI has showed a −4.36% decrease.
We've gathered analysts' opinions on SANOFI future price: according to them, 4SAN price has a max estimate of 127.00 EUR and a min estimate of 99.00 EUR. Watch 4SAN chart and read a more detailed SANOFI stock forecast: see what analysts think of SANOFI and suggest that you do with its stocks.
4SAN reached its all-time high on Mar 6, 2025 with the price of 110.12 EUR, and its all-time low was 63.16 EUR and was reached on Feb 9, 2018. View more price dynamics on 4SAN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4SAN stock is 2.71% volatile and has beta coefficient of 0.60. Track SANOFI stock price on the chart and check out the list of the most volatile stocks — is SANOFI there?
Today SANOFI has the market capitalization of 101.26 B, it has decreased by −4.24% over the last week.
Yes, you can track SANOFI financials in yearly and quarterly reports right on TradingView.
4SAN net income for the last half-year is 3.31 B EUR, while the previous report showed 2.25 B EUR of net income which accounts for 47.55% change. Track more SANOFI financial stats to get the full picture.
Yes, 4SAN dividends are paid annually. The last dividend per share was 3.92 EUR. As of today, Dividend Yield (TTM)% is 4.72%. Tracking SANOFI dividends might help you take more informed decisions.
SANOFI dividend yield was 4.18% in 2024, and payout ratio reached 88.23%. The year before the numbers were 4.19% and 87.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 20, 2025, the company has 84.59 K employees. See our rating of the largest employees — is SANOFI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANOFI EBITDA is 13.14 B EUR, and current EBITDA margin is 31.98%. See more stats in SANOFI financial statements.
Like other stocks, 4SAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANOFI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANOFI technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANOFI stock shows the strong sell signal. See more of SANOFI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.